- Home
- PLRX vs NCMI Comparison
PLRX vs NCMI Comparison
Compare PLRX & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- NCMI
- Stock Information
- Founded
- PLRX 2015
- NCMI 2005
- Country
- PLRX United States
- NCMI United States
- Employees
- PLRX N/A
- NCMI N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- NCMI Advertising
- Sector
- PLRX Health Care
- NCMI Consumer Discretionary
- Exchange
- PLRX Nasdaq
- NCMI Nasdaq
- Market Cap
- PLRX 682.2M
- NCMI 653.0M
- IPO Year
- PLRX 2020
- NCMI 2007
- Fundamental
- Price
- PLRX $11.07
- NCMI $6.70
- Analyst Decision
- PLRX Strong Buy
- NCMI Strong Buy
- Analyst Count
- PLRX 7
- NCMI 4
- Target Price
- PLRX $40.50
- NCMI $7.56
- AVG Volume (30 Days)
- PLRX 544.0K
- NCMI 586.9K
- Earning Date
- PLRX 02-26-2025
- NCMI 03-17-2025
- Dividend Yield
- PLRX N/A
- NCMI N/A
- EPS Growth
- PLRX N/A
- NCMI N/A
- EPS
- PLRX N/A
- NCMI N/A
- Revenue
- PLRX N/A
- NCMI $245,300,000.00
- Revenue This Year
- PLRX N/A
- NCMI $47.09
- Revenue Next Year
- PLRX N/A
- NCMI $19.46
- P/E Ratio
- PLRX N/A
- NCMI N/A
- Revenue Growth
- PLRX N/A
- NCMI 47.68
- 52 Week Low
- PLRX $10.22
- NCMI $3.66
- 52 Week High
- PLRX $18.92
- NCMI $7.60
- Technical
- Relative Strength Index (RSI)
- PLRX 36.41
- NCMI 53.32
- Support Level
- PLRX $10.94
- NCMI $5.93
- Resistance Level
- PLRX $12.70
- NCMI $6.86
- Average True Range (ATR)
- PLRX 0.77
- NCMI 0.27
- MACD
- PLRX -0.18
- NCMI 0.04
- Stochastic Oscillator
- PLRX 4.69
- NCMI 71.96
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About NCMI National CineMedia Inc.
National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.